<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03721445</url>
  </required_header>
  <id_info>
    <org_study_id>07-XD-093</org_study_id>
    <nct_id>NCT03721445</nct_id>
  </id_info>
  <brief_title>Could HRV be a Valuable Predictor for CPAP Adherence?</brief_title>
  <official_title>If Heart Rate Variability Can Predict Continuous Positive Airway Pressure Acceptance and Compliance for Patients With Obstructive Sleep Apnea ?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aim to evaluate if the improvement of heart rate variability for the continuous
      positive airway pressure titration night can predict the short and long term continuous
      positive airway pressure adherence for patients with moderate to severe OSA.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Heart rate variability (HRV) represents autonomic regulation and had been used in varies
      situation, especially the associated with cardiovascular outcomes and psychological diseases.
      HRV was also well known associated with the severity of obstructive sleep apnea (OSA) and
      could be improved after adequate treatments for OSA. Continuous positive airway pressure
      (CPAP) is the first choice of treatment for OSA and had been proved to able to improve HRV in
      OSA patients. However, the CPAP adherence is always problematic. Many CPAP predictors had
      been well documented but the HRV is never evaluated to be a potential predictor of CPAP
      adherence.

      Therefore, this study will evaluate the changes of HRV for polysomnography (PSG) night, for
      CPAP titration night to see if the changes of HRV in the CPAP titration night could predict
      CPAP adherence for OSA patients in Taiwan.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 2, 2018</start_date>
  <completion_date type="Anticipated">March 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>6 Months</target_duration>
  <primary_outcome>
    <measure>If changes in LF/HF ratio (Low frequency/High frequency ratio) could be a valuable predictor for CPAP acceptance in OSA patients?</measure>
    <time_frame>1 month</time_frame>
    <description>Changes of LF/HF ratio between PSG study night and CPAP titration night will be measured and evaluated its association with CPAP acceptance of one month CPAP trial at home in moderate to severe OSA patients.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>If CPAP treatment could improve LF/HF ratio after 6 months of treatment in moderate to severe OSA patients?</measure>
    <time_frame>6 months</time_frame>
    <description>After CPAP treatments 6 months, PSG examination will be followed-up again. The changes of LF/HF ratio between baseline PSG and 6-months PSG will be measured and be evaluated it's differences between different CPAP usage pattern (no any use in CPAP opponents, suboptimal use in CPAP acceptors and optimal use in CPAP acceptors ).</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">192</enrollment>
  <condition>OSA</condition>
  <condition>Autonomic Dysfunction</condition>
  <condition>PAP</condition>
  <condition>Adherence, Patient</condition>
  <arm_group>
    <arm_group_label>CPAP opponent</arm_group_label>
    <description>CPAP opponent: moderate to severe OSA patients who refused CPAP therapy after PSG study and CPAP titration test.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CPAP acceptor</arm_group_label>
    <description>CPAP acceptor: moderate to severe OSA patients who accepted CPAP therapy after PSG study and CPAP titration test and had purchased a PAP at home for long term use.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>continuous positive airway pressure</intervention_name>
    <description>Could the changes of HRV between PSG night and CPAP titration night predict the CPAP adherence?</description>
    <arm_group_label>CPAP acceptor</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        moderate to severe OSA patients proved by PSG study and had been received CPAP titration
        test and had been prescribed CPAP therapy at home.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. aged:20~75y/o

          2. PSG revealed moderate to severe OSA (apnea hypopnea index [AHI] â‰§15/hour)

          3. had been completed CPAP titration test

        Exclusion Criteria:

          1. aged&lt;20y/o or &gt;75 y/o

          2. mild OSA, (AHI &lt;15/hour), or no OSA (AHI&lt;5/hour)

          3. unstable cardiopulmonary disease, psychological diseases, using sleep pills.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mei-Chen Yang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mei-Chen Yang, MD</last_name>
    <phone>886-66289779</phone>
    <phone_ext>5709</phone_ext>
    <email>mimimai3461@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mei-Chen Yang Yang, MD</last_name>
    <phone>886-66289779</phone>
    <phone_ext>5709</phone_ext>
    <email>mimimai3461@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mei-Chen Yang</name>
      <address>
        <city>New Taipei City</city>
        <zip>23142</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mei-Chen Yang, MD</last_name>
      <phone>886066289779</phone>
      <phone_ext>5709</phone_ext>
      <email>mimimai3461@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Taipei Tzu-Chi Hospital, Buddhist Tzu-Chi Medical Foundation</name>
      <address>
        <city>New Taipei</city>
        <zip>23143</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mei-Chen Yang, MD</last_name>
      <phone>+886-66289779</phone>
      <phone_ext>5709</phone_ext>
      <email>mimimai3461@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <reference>
    <citation>Noda A, Yasuma F, Okada T, Yokota M. Circadian rhythm of autonomic activity in patients with obstructive sleep apnea syndrome. Clin Cardiol. 1998 Apr;21(4):271-6.</citation>
    <PMID>9562937</PMID>
  </reference>
  <reference>
    <citation>Palma JA, Iriarte J, Fernandez S, Alegre M, Valencia M, Artieda J, Urrestarazu E. Long-term continuous positive airway pressure therapy improves cardiac autonomic tone during sleep in patients with obstructive sleep apnea. Clin Auton Res. 2015 Aug;25(4):225-32. doi: 10.1007/s10286-015-0297-7. Epub 2015 May 23.</citation>
    <PMID>26001693</PMID>
  </reference>
  <reference>
    <citation>Walter LM, Biggs SN, Nisbet LC, Weichard AJ, Hollis SL, Davey MJ, Anderson V, Nixon GM, Horne RS. Improved long-term autonomic function following resolution of sleep-disordered breathing in preschool-aged children. Sleep Breath. 2016 Mar;20(1):309-19. doi: 10.1007/s11325-015-1268-x. Epub 2015 Oct 2.</citation>
    <PMID>26432070</PMID>
  </reference>
  <reference>
    <citation>Gong X, Huang L, Liu X, Li C, Mao X, Liu W, Huang X, Chu H, Wang Y, Wu W, Lu J. Correlation Analysis between Polysomnography Diagnostic Indices and Heart Rate Variability Parameters among Patients with Obstructive Sleep Apnea Hypopnea Syndrome. PLoS One. 2016 Jun 2;11(6):e0156628. doi: 10.1371/journal.pone.0156628. eCollection 2016.</citation>
    <PMID>27253187</PMID>
  </reference>
  <reference>
    <citation>Terziyski KV, Draganova AI, Taralov ZZ, Ilchev IS, Kostianev SS. The effect of continuous positive airway pressure on heart rate variability during the night in patients with chronic heart failure and central sleep apnoea. Clin Exp Pharmacol Physiol. 2016 Dec;43(12):1185-1190. doi: 10.1111/1440-1681.12662.</citation>
    <PMID>27560005</PMID>
  </reference>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>October 15, 2018</study_first_submitted>
  <study_first_submitted_qc>October 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 26, 2018</study_first_posted>
  <last_update_submitted>October 24, 2018</last_update_submitted>
  <last_update_submitted_qc>October 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation</investigator_affiliation>
    <investigator_full_name>Mei-Chen Yang</investigator_full_name>
    <investigator_title>Attending physician</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Autonomic Nervous System Diseases</mesh_term>
    <mesh_term>Primary Dysautonomias</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

